Santen Pharmaceutical Co., Ltd. (SNPHY)
Total Non-Current Liabilities
¥39.90B
Quarterly · Period ending: · JPY

SNPHY Total Non-Current Liabilities
What is total non-current liabilities?
Long-term obligations due beyond one year.
SNPHY total non-current liabilities history
Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Total Non-Current Liabilities (JPY) | Change |
|---|---|---|
| 39,317,791,000 | +5.53% | |
| 37,259,000,000 | −0.73% | |
| 37,534,000,000 | −2.20% | |
| 38,378,000,000 | +40.52% | |
| 27,311,000,000 | +63.01% | |
| 16,754,000,000 | −56.61% | |
| 38,611,000,000 | +1.74% | |
| 37,951,000,000 | −1.95% | |
| 38,705,000,000 | +150.36% | |
| 15,460,000,000 | −30.23% | |
| 22,160,000,000 | −38.58% | |
| 36,081,000,000 | +233.99% | |
| 10,803,000,000 | +44.10% | |
| 7,497,000,000 | +15.07% | |
| 6,515,000,000 | +51.76% | |
| 4,293,000,000 | +7.62% | |
| 3,989,000,000 | +24.46% | |
| 3,205,000,000 | +11.75% | |
| 2,868,000,000 | −64.52% | |
| 8,084,000,000 | +4.84% | |
| 7,711,000,000 | −18.99% | |
| 9,519,000,000 | — |
Frequently asked questions: SNPHY total non-current liabilities
What is Santen Pharmaceutical Co., Ltd. (SNPHY)'s current total non-current liabilities?
Santen Pharmaceutical Co., Ltd. (SNPHY)'s latest reported total non-current liabilities (Quarterly) is ¥39.90B as of Sep 30, 2026. Long-term obligations due beyond one year.
How much historical total non-current liabilities data is available for SNPHY?
Stock Alarm Pro provides 22 dated annual fiscal periods observations for Santen Pharmaceutical Co., Ltd. (SNPHY)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare SNPHY's total non-current liabilities to peers or set an alert?
You can open SNPHY's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on SNPHY delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance